Molecular imaging has experienced enormous advancements in the areas of imaging
technology, imaging probe and contrast development, and data quality, as well as machine …

Purpose The study aimed to provide a comprehensive bibliometric overview of the current
scientific publications on fibroblast activation protein inhibitor (FAPI) positron emission …

Despite revolutionizing the field of oncological imaging, Positron Emission Tomography
(PET) with [18F] Fluorodeoxyglucose (FDG) as its workhorse is limited by a lack of specificity …

Cancer cells are surrounded by a complex and highly dynamic tumor microenvironment
(TME). Cancer-associated fibroblasts (CAFs), a critical component of TME, contribute to …

Since the development of fibroblast activation protein–targeted radiopharmaceuticals, 68Ga-
fibroblast activation protein inhibitor (FAPI) PET/CT has been found to be suitable for …

Purpose Digestive system tumors are a group of tumors with high incidence in the world
nowadays. The assessment of digestive system tumor metastasis by conventional imaging …

BACKGROUND Improving and predicting tumor response to immunotherapy remains
challenging. Combination therapy with a transforming growth factor-β receptor (TGF-βR) …

FAPI PET/CT is a novel imaging tool targeting fibroblast activation protein (FAP), with high
tumor uptake rate and low background noise. Therefore, the appearance of FAPI PET/CT …

FAPI-based radiopharmaceuticals are a novel class of tracers, mainly used for PET imaging,
which have demonstrated several advantages over [18F] FDG, especially in the case of low …

Simple Summary Fibroblast activation protein is a newly discovered biomarker in various
tumor types. Using inhibitors ligated with radiopharmaceuticals, nuclear medicine …